Abstract
The objective of this study was to determine whether adenosine A1 or A2 receptor was responsible for the regulation of protein kinase C (PKC) in porcine coronary artery and its coupling to G-protein. Endothelium denuded arterial rings were incubated with PDBu (200nM) in the presence or absence of adenosine receptor agonists and antagonists for 1 day. Following incubation, the arterial rings were contracted with increasing concentrations of endothelin-1 (ET-1) (10−10−10−7M). Arteries incubated with PDBu alone failed to produce contraction in response to ET-1. On the contrary, inclusion of A1 receptor agonist ENBA at 10−9M in the incubation media with PDBu protected against the PDBu induced blunting of the ET-1 contractions by 50%. Incubation with ENBA alone increased ET-1 dependent contractions by about 2 fold. Inclusion of A1 receptor antagonist, N0861 at 10−6 M along with PDBu and ENBA, completely blocked the protective effect of ENBA against the PDBu induced attenuation of ET-1 contractions. N0861 also completely blocked the increase in ET-1 contractions in the arterial rings incubated with ENBA alone. Another A1 receptor antagonist DPCPX also produced similar results as N0861. On the contrary, arterial rings incubated with relatively specific A2 receptor agonist CGS 21680 at 10−4M did not produce any protection against PDBu induced blunting of the ET-1 contractions. Incubation with CGS 21680 alone also did not significantly alter the ET-1 contractions. Interestingly, inclusion of A2 receptor antagonist DMPX at 10−4M in the incubation media along with CGS 21680 mimicked the effects of ENBA alone i.e. produced protection against PDBu and enhanced ET-1 contractions. Incubation of the arteries with ENBA alone caused an accumulation of PKC levels, whereas, incubation with CGS 21680 had no significant effect on PKC levels. To study the coupling of adenosine receptor with G-protein, the tissue was incubated for one day with cholera (CT) or pertussis toxin (PT) in the presence or absence or ENBA and PDBu as described above. Incubation with PT blocked the protective effect of ENBA against PDBu as well as the elevation of ET-1 response when incubated with ENBA alone. On the contrary, incubation with CT did not produce any significant effect on ENBA responses. These results indicate that PKC is modulated by adenosine via A1 adenosine receptors and through a PT sensitive G-protein.
Similar content being viewed by others
Abbreviations
- A2-R:
-
adenosine A2 receptor
- Gs :
-
stimulatory guanine nucleotide binding protein
- AC:
-
adenylate cyclase
- A1-R:
-
adenosine A1 receptor
- Gi :
-
inhibitory guanine nucleotide binding protein
- P:
-
protein kinase C specific protease
- PKC:
-
protein kinase C
- ET-1 R:
-
endothelin-1 receptor
- G:
-
guanine nucleotide binding protein
- PLC:
-
phospholipase C
- PIP2 :
-
phosphatidylinositol 4,5-bisphosphate
- DAG:
-
diacylglycerol
- IP3 :
-
d-myo-inositol 1,4,5-triphosphate
References
Mustafa SJ: Cellular and molecular mechanism(s) of coronary flow regulation by adenosine. Mol Cell Biochem 31: 61–87, 1980
Kusachi S, Thompson RD, Olsson RA: Ligand selectivity of dog coronary adenosine receptor resembles that of adenylate cyclase stimulatory (Ra) receptors. J Pharmacol Exp Ther 227: 316–321, 1983
Libert F, Schiffmann SN, Lefort A et al: The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor. EMBO J, 10: 1677–1682, 1991
Maenhaut C, Sande JV, Libert F, Abramowicz M, Parmentier M, Vanderhaegen J-J, Dumont JE, Vassart G, Schiffmann S: RDC8 codes for an adenosine A2 receptor with physiological constitutive activity. Biochem Biophys Res Commun 173(3): 1169–1178, 1990
Rivkees SA, Reppert SM: RFL9 encodes an A2b-adenosine receptor. Mol. Endocrinol 6: 1598–1604, 1992
Stehle JH, Rivkees SA, Lee JJ, Weaver DR, Deeds JD, Reppert SM: Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype. Mol Endocrinol 6: 384–393, 1992
Zhou Q-Y, Li C, Olah ME, Johnson RA, Stiles GL, Civelli O: Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proc Natl Acad Sci USA 89: 7432–7436, 1992
Linden J, Taylor HE, Robeva AS, Tucker AL, Stehle JH, Rivkees SA, Fink JS, Reppert SM: Molecular cloning and functional expression of a sheep A1 adenosine receptor with widespread tissue distribution. Mol Pharmacol 44: 524–532, 1993
Kukovetz WR, Wurm A, Holzmann S, Poch G, Rinner I: Evidence for an adenylate cyclase-linked adenosine receptor mediating coronary relaxation. In: H.P. Baer and G.I Drummond (eds). Physiological and regulatory functions of adenosine and adenine nucleotides. Raven Press, 1979, pp. 205–213
Silver PJ: Adenosine-mediated relaxation and activation of cyclic-AMP dependent protein kinase in coronary arterial smooth muscle. J Phar Exp Ther 228: 342–347, 1984
Cassis LA, Loeb AL, Peach MJ: Mechanisms of adenosine- and ATP-induced relaxation in rabbit femoral artery: role of endothelium and cyclic nucleotides. In: E. Gerlach and B.F. Becker (eds). Topics and perspectives in adenosine research. Springer-Verlag, 1987, pp. 486–496
Sabouni MH, Hussain T, Cushing DJ, Mustafa SJ: G proteins subserve relaxations mediated by adenosine receptors in human coronary artery. J Cardiovasc Pharmacol 18: 696–702, 1991
Cushing DJ, Makujina SR, Sabouni MH, Mustafa SJ: Protein kinase C and phospholipase C in adenosine receptor-mediated relaxation in coronary artery. Am J Physiol (Heart Circ Physiol 30): H1848-H1854, 1991
Sabouni MH, Cushing DJ, Mustafa SJ: Adenosine receptor-mediated relaxation in coronary artery: Evidence for a guanyl nucleotide-binding regulatory protein involvement. J Pharmacol Exp Ther 251: 943–948, 1989
Ramagopal MV, Mustafa SJ: Effect of adenosine and its analogues on calcium influx in coronary artery. Am J Phys 255 (Heart Circ Physiol 24): H1492-H1498, 1988
Long CJ, Stone TW: Adenosine reduces agonist induced production of inositol phosphates in rat aorta. J Pharm Pharmacol 39: 1010–1014 1987
Dockrow SR and Lowenstein JM: Adenosine and 5′-chloro-5′-deoxyadenosine inhibit the phosphorylation of phosphatidylinositol and myosin light chain in calfaorta smooth muscle. J Biol Chem 260: 3469–3476, 1985
Docktrow SR, Lowenstein JM: Inhibition of phosphatidylinositol kinase in vascular smooth muscle membranes by adenosine and related compounds. Biochem Pharm 36: 2255–2262, 1987
Hussain T, Mustafa SJ: Effects of adenosine analogues on ADP-ribosylation of Gs protein in coronary artery. Am J Physiol 262 (Heart Circ Physiol 31): H875-H879, 1992
Marala RB, Mustafa SJ: Direct evidence for the coupling of A2-adenosine receptor to Gs-protein in bovine brain striatum. J Pharmacol Exp Ther 266(1): 294–300, 1993
Munshi R, Pang I-H, Sternweis PC, Linden J: Al adenosine receptors of bovine brain coupled to guanine nucleotide-binding proteins Gil, Gi2, and Go. J Biol Chem 266(33): 22285–22289, 1991
Singer HA: Phorbol ester-induced stress and myosin light chain phosphorylation in swine carotid medial smooth muscle. J Phar Exp Ther. 252: 1068–1074, 1990
Ratz PH: Effect of kinase inhibitor, H-7, on stress, crossbridge phosphorylation, muscles shortening and inositol phosphate production in rabbit arteries. J Phar Exp Ther 252: 253 1990
Suba EA, Roth BL: Prostaglandins activate phosphoinositide metabolism in rat aorta. Eur J Pharmacol 136: 325–332 1987
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaka Y, Goto K, Masaki T: Anovel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–415, 1988
Kasuya Y, Ishikawa T, Yanagisawa M, Kimura S, Goto K, Masaki T: Mechanism of contraction to endothelin in isolated porcine coronary artery. Am J Physiol 257 (Heart Cire Physiol 26), H1828-H1835, 1989
Resink TJ, Scott-Burden T, Buhler FR: Endothelin stimulates phospholipase C in cultured vascular smooth muscle cells. Biochem Biophys Res Commun 157: 1360–1368, 1988
Muldoon LL, Rodland KD, Forsythe ML, Magun BE: Stimulation of phosphatidylinositol hydrolysis, diacylglycerol release, and gene expression in response to endothelin, a potent new agonist for fibroblasts and smooth muscle cells. J Biol Chem 264: 8529–8536, 1989
Griendling KK, Tsuda T, Alexander RW: Endothelin stimulates diacylglycerol accumulation and activates protein kinase C in cultured vascular smooth muscle cells. J Biol Chem 264: 8237–8240, 1989
Lee T-E, Thao T, Hu K-Q, King GL: Endothelin stimulates a sustained 1,2-diacylglycerol increase and protein kinase C activation in bovine aortic smooth muscle cells. Biochem Biophys Res Commun 162: 381–386, 1989
Nishizuka Y: Studies and perspectives of protein kinase C. Science 233: 305–312, 1986
Rasmussen H, Takuwa Y, Park S: Protein kinase C in the regulation of smooth muscle contraction. FASEB J 1: 177–185, 1987
Marala RB, Ways K, Mustafa SJ: 2-Chloroadenosine prevents phorbol ester-induced depletion of protein kinase C in porcine coronary artery. Am J Physiol 264 (Heart and Circ Physiol 33) H1465–1471, 1993
Merkel LA, Rivera LM, Colussi DJ, Perrone MH: Protein kinase C and vascular smooth muscle contractility: Effects of inhibitors and down-regulation. J Phar Exp Ther 257: 134–140, 1991
Bradley JD, Zanaboni PB, Webster RO, Baudendistel LJ, Dahms TE: Adenosine prevents phorbol ester injury in rabbit lungs: role of leukotrienes and TNF. J Appl Physiol 71(5): 1949–1955, 1991
Marala RB, Mustafa SJ: Adenosine analogs prevents phorbol esterinduced protein kinase C depletion in porcine coronary artery via adenosine A1 receptor. (Abstract # 1047) Drug Development Res 31(4): 294, 1994
Hussain T, Mustafa SJ: Anin vitro pharmacological model of vascular smooth muscle. J Pharmacol Toxicol Meth 30(2): 111–115, 1993
Ballester R, Rosen OM: Fate of immunoprecipitable protein kinase C in GH3 cells treated with phorbol 12-myristate 13-acetate. J Biol Chem 260: 15194–15199, 1985
Stabel S, Rodriguez-Pena A, Rozengurt E, Parker PJ: Quantitation of protein kinase C by immunoblot-Expression in different cell lines and response to phorbol ester. J Cell Physiol 130: 111–117, 1987
Young S, Parker PJ, Ullrich A, Stabel S: Down-regulation of protein kinase C is due to an increased rate of degradation. Biochem J 244: 775–779, 1987
Gill DM, Meren R: ADP-ribosylation of membranes catalyzed by cholera toxin: basis of the activation of adenylate cyclase. Proc Natl Acad Sci USA 75: 3050–3054, 1978
Cassel D, Pfeuffer T: Mechanism of cholera toxin action: covalent modification of guanyl nucleotide-binding protein of the adenylate cyclase system. Proc Natl Acad Sci USA 75: 2669–2673, 1978
Moss J, Vaughan M: Mechanism of action of choleragen: Evidence for ADP-ribosyltransferase activity with arginine as an acceptor. J Biol Chem 252: 2455–2457, 1977
Katada T, Ui M: ADP ribosylation of specific membrane protein of C6 cells by islet-activating protein associated with modification of adenylate cyclase activity. J Biol Chem 257: 7210–7216, 1982
Hurley JB, Simon MI, Teplow DB, Robishaw JD, Gilman AG: Homologies between signal transducing G proteins and ras gene products. Science 226: 860–862, 1984
West RE Jr, Moss J, Vaughan M, Liu T, Liu T-Y: Pertussis toxincatalyzed ADP-ribosylation of transducin. Cysteine 347 is the ADP-ribose acceptor site. J Biol Chem 260: 14428–14430, 1985
Kahn RA, Gilman AG: ADP-ribosylation of Gs promotes the dissociation of its α and β subunits. J Biol Chem 259: 6235–6240, 1984
VanCalker D, Muller M, Hamprecht B: Adenosine regulates via two different types of receptors the accumulation of cyclic AMP in cultured brain cells. J Neurochem 33: 999–1005, 1979
Londos C, Cooper DMF, Wolff J: Subclasses of external adenosine receptors. Proc Natl Acad Sci USA 77: 2551–2554, 1980
Bruns RF: Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists. Can J Physiol Pharmacol 58: 673–691, 1980
Baer HP, Vriend P: Adenosine receptors in smooth muscle: structure-activity studies and the question of adenylate cyclase involvement in control of relaxation. Can J Physiol Pharmacol 63: 972–977, 1985
Downey JM, Liu GS, Thornton JD: Adenosine and the anti-infarct effects of preconditioning. Cardiovascular Res 27(1): 3–8, 1993
Lasley RD, Barakat O, Van Wylen D G.L, Mentzer RM: Pertussis toxin inhibits adenosine-mediated presevation of postischemic myocardial function (Abstract) Circulation 84(suppl II): II-307 #1220, 1991
Strasser R H, Walendzik H, Marquetant R: Prolonged myocardial ischemia provokes an induction of protein kinase C activity. (Abstract) Circulation 84(suppl II):II-620, #2463, 1991
Mitchell MB, Parker CG, Meng X, Brew EC, Ao L, Brown JM, Harken AH, BanerjeeA: Protein kinase C mediates preconditioning in isolated rat heart. Circulation 88(#4, part 2) #3405, 1993
Stawski G, Olsen UB, Grande P: Cytotoxic effect of endothelin-1 during ischemia in cultured neonatal rat myocytes. (Abstract) Circulation 84(suppl II):II-616, #2450, 1991
Author information
Authors and Affiliations
Additional information
This work was supported by National Heart, Lung and Blood Institute Grant HL-27339.
Rights and permissions
About this article
Cite this article
Marala, R.B., Mustafa, S.J. Modulation of protein kinase C by adenosine: Involvement of adenosine A1 receptor-pertussis toxin sensitive nucleotide binding protein system. Mol Cell Biochem 149, 51–58 (1995). https://doi.org/10.1007/BF01076563
Issue Date:
DOI: https://doi.org/10.1007/BF01076563